لعقود من الزمن، اعتمد تشخيص داء السكري على تجاوز قياسات سكر الدم لعتبة محددة. ويخشى الباحثون الآن أن هذه الطريقة تغفل ملايين الأشخاص الذين بدأوا بالفعل في تطوير المرض، لذا يجري العمل على تطوير أدوات كشف أكثر دقة لمعالجة هذه القصور.
لطالما اعتمد الأطباء على مستويات جلوكوز الدم لتحديد خطر الإصابة بالسكري. ورغم فعالية هذا النهج مع الكثيرين، إلا أنه لا يفي بالغرض لدى فئات معينة من السكان حيث يتطور المرض دون ارتفاعات واضحة في سكر الدم.
من إعداد الذكاء الاصطناعي صورة مولدة بواسطة الذكاء الاصطناعي
A new Karolinska Institutet study finds that children with moderate obesity face higher risks of type 2 diabetes, high blood pressure, and lipid disorders in adulthood, even without apparent risk markers. Researchers urge treatment for all such children.
New research published in Nature Medicine reveals that people with prediabetes can normalize blood sugar levels without losing weight. About one in four participants in lifestyle programs achieved this remission, offering protection against diabetes similar to weight loss methods. The key factors involve fat distribution and certain hormones.
من إعداد الذكاء الاصطناعي
Scientists at Washington University School of Medicine in St. Louis have developed a blood test that estimates when Alzheimer's symptoms may begin, using levels of the protein p-tau217. The model predicts onset within about three to four years, potentially aiding clinical trials and early interventions. This advance relies on data from 603 older adults in ongoing studies.
Researchers at UCL have identified a protein called LRG1 that initiates the earliest damage in diabetic retinopathy, a major cause of vision loss in adults with diabetes. In mouse studies, blocking LRG1 prevented retinal harm and preserved eye function. The findings suggest potential for new preventive treatments targeting this protein.
من إعداد الذكاء الاصطناعي
New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.